Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?

被引:27
作者
Breccia, M
Petti, MC
Testi, AM
Specchia, G
Ferrara, F
Diverio, D
Romano, A
Guerrisi, V
Greco, A
Fiorella, ML
de Vincentis, M
Mandelli, F
Lo Coco, F
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[2] Univ Roma La Sapienza, Dept Radiol, Rome, Italy
[3] Univ Roma La Sapienza, Dept Otorhinolaryngol, Rome, Italy
[4] Univ Bari, Dept Hematol, Bari, Italy
[5] Osp A Carolaretti, Dept Hematol, Naples, Italy
关键词
acute promyelocytic leukemia; ear localization; PML/RAR alpha; extramedullary APL;
D O I
10.1038/sj.leu.2402497
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extramedullary (EM) involvement occurs infrequently in acute promyelocytic leukemia (APL) and usually involves skin and CNS. We describe seven patients (four observed at a single institution) who relapsed in various sites of the auditory apparatus, including the external canal and middle ear (temporal bone). Front-line treatment included ATRA and chemotherapy (six patients) or chemotherapy alone (one patient). Three patients had concomitant hematologic relapse, two had molecular relapse and two were in hematologic and molecular remission when ear localization was documented. Local symptoms that stimulated further diagnostic studies included ear bleeding/discharge in the first patient, but were mild in the others (hypoacusia, five patients; earache, two patients). Ear involvement by leukemia was documented by histological and/or molecular studies after local surgery in five cases, and by CT scan or NMR in the remaining patients. We suggest that the ear might represent a specific sanctuary for disease involvement in APL.
引用
收藏
页码:1127 / 1130
页数:4
相关论文
共 32 条
  • [11] CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
    Ferrara, F
    Morabito, F
    Martino, B
    Specchia, G
    Liso, V
    Nobile, F
    Boccuni, P
    Di Noto, R
    Pane, F
    Annunziata, M
    Schiavone, EM
    De Simone, M
    Guglielmi, C
    Del Vecchio, L
    Lo Coco, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1295 - 1300
  • [12] Goto H, 1998, Rinsho Ketsueki, V39, P1169
  • [13] Kikuno K, 1996, Rinsho Ketsueki, V37, P323
  • [14] Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia -: the occurrence of retinoic acid syndrome is a risk factor
    Ko, BS
    Tang, JL
    Chen, YC
    Yao, M
    Wang, CH
    Shen, MC
    Tien, HF
    [J]. LEUKEMIA, 1999, 13 (09) : 1406 - 1408
  • [15] Liso V, 1998, CANCER, V83, P1522, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1522::AID-CNCR6>3.0.CO
  • [16] 2-4
  • [17] Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia
    Lo Coco, F
    Diverio, D
    Falini, B
    Biondi, A
    Nervi, C
    Pelicci, PG
    [J]. BLOOD, 1999, 94 (01) : 12 - 22
  • [18] Mandelli F, 1997, BLOOD, V90, P1014
  • [19] All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4
    Marchetti, M
    Falanga, A
    Giovanelli, S
    Oldani, E
    Barbui, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) : 360 - 366
  • [20] Recurrence of childhood acute lymphoblastic leukemia presenting as a tumor of the middle ear: A case report
    Millot, F
    Klossek, JM
    Brizard, F
    Brizard, A
    Vandermarq, P
    Babin, P
    Guilhot, F
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) : 351 - 353